Read + Share
Hu S, Shi C, Ma Y, Wang S, et al. Cost-utility analysis and drug pricing for tirzepatide for type 2 diabetes in the
Chinese market compared with semaglutide. Diabetes Obes Metab 2024 May 13. doi: 10.1111/dom.15645.
PMID: 38738340
|
 |
|
Hu S, Shi C, Ma Y, Wang S, et al. Cost-utility analysis and drug pricing for tirzepatide for type 2 diabetes in the
Chinese market compared with semaglutide. Diabetes Obes Metab 2024 May 13. doi: 10.1111/dom.15645.
PMID: 38738340
|
|
|
|